Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ADJUVANT IMMUNOTHERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 28 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Azuma, I; Seya, T
      Development of immunoadjuvants for immunotherapy of cancer

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Wood, TF; DiFronzo, LA; Rose, DM; Haigh, PL; Stern, SL; Wanek, L; Essner, R; Morton, DL
      Does complete, resection of melanoma metastatic to solid intra-abdominal organs improve survival?

      ANNALS OF SURGICAL ONCOLOGY
    3. Singh, B; Delovitch, TL
      Immune mechanisms that regulate susceptibility to autoimmune type I diabetes

      CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
    4. Balch, CM; Morton, DL
      Second-time surgery for stage IV sarcoma (A model of sequential metastases)

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    5. Singh, BN; Dwivedi, C
      Antitumor drug delivery by tissue electroporation

      ANTI-CANCER DRUGS
    6. Nemunaitis, J
      Oncolytic viruses

      INVESTIGATIONAL NEW DRUGS
    7. SHRAYER DP; BOGAARS H; HEARING VJ; WOLF SF; WANEBO HJ
      A NEW MOUSE MODEL OF EXPERIMENTAL MELANOMA FOR VACCINE AND LYMPHOKINETHERAPY

      International journal of oncology
    8. HAYASHI A; DOI O; AZUMA I; TOYOSHIMA K
      IMMUNO-FRIENDLY USE OF BCG CELL-WALL SKELETON REMARKABLY IMPROVES THESURVIVAL RATE OF VARIOUS CANCER-PATIENTS

      Proceedings of the Japan Academy. Series B Physical and biological sciences
    9. MARTINETTI A; SEREGNI E; BELLI F; MAZZOCCHI A; AGRESTI R; CASCINELLI N; GRECO M; BOMBARDIERI E
      EVALUATION ON SERUM 2'-5' OLIGOADENYLATE SYNTHETASE (2'-5' OLIGOAS) AND BETA-2-MICROGLOBULIN (B2M) IN PATIENTS WITH NODAL METASTASES FROM CUTANEOUS MALIGNANT-MELANOMA TREATED WITH RIFN-ALPHA-2A

      Anticancer research
    10. Chan, AD; Morton, DL
      Active immunotherapy with allogeneic tumor cell vaccines: Present status

      SEMINARS IN ONCOLOGY
    11. CARACENI A; GANGERI L; MARTINI C; BELLI F; BRUNELLI C; BALDINI M; MASCHERONI L; LENISA L; CASCINELLI N
      NEUROTOXICITY OF INTERFERON-ALPHA IN MELANOMA THERAPY - RESULTS FROM A RANDOMIZED CONTROLLED TRIAL

      Cancer
    12. HAYAKAWA K; MITSUHASHI N; SAITO Y; NAKAYAMA Y; FURUTA M; NAKAMOTO S; KAWASHIMA M; NIIBE H
      EFFECT OF KRESTIN AS ADJUVANT TREATMENT FOLLOWING RADICAL RADIOTHERAPY IN NONSMALL CELL LUNG-CANCER PATIENTS

      Cancer detection and prevention
    13. EVERSE LA; BERNSEN MR; DULLENS HFJ; DENOTTER W
      PRIMING OF THE ANTITUMOR RESPONSE PROMOTES EFFICACY OF INTERLEUKIN-2 THERAPY

      Cancer immunology and immunotherapy
    14. LORENZ M; WALDEYER M; ENCKE A
      DISAGREEMENT ON THE STANDARD ADJUVANT TRE ATMENT FOR COLON-CANCER

      Zentralblatt fur Chirurgie
    15. HEIKE Y; TAKAHASHI M; OHIRA T; NARUSE I; HAMA S; OHE Y; KASAI T; FUKUMOTO H; OLSEN KJ; PODACK EE; SAIJO N
      GENETIC IMMUNOTHERAPY BY INTRAPLEURAL, INTRAPERITONEAL AND SUBCUTANEOUS INJECTION OF IL-2 GENE-MODIFIED LEWIS LUNG-CARCINOMA CELLS

      International journal of cancer
    16. JONES RC; KELLEY M; GUPTA RK; NIZZE JA; YEE R; LEOPOLDO Z; QI K; STERN S; MORTON DL
      IMMUNE-RESPONSE TO POLYVALENT MELANOMA CELL VACCINE IN AJCC STAGE-IIIMELANOMA - AN IMMUNOLOGICAL SURVIVAL MODEL

      Annals of surgical oncology
    17. TAKESHITA K; HAYASHI S; TANI M; KANDO F; SAITO N; ENDO M
      MONOCYTE FUNCTION-ASSOCIATED WITH INTERMITTENT LENTINAN THERAPY AFTERRESECTION OF GASTRIC-CANCER

      Surgical oncology
    18. JASSEM J
      BIOLOGICAL TREATMENT OF NSCLC - THE NEED FOR CONCLUSIVE STUDIES

      Chest
    19. FUJISAWA T; YAMAGUCHI Y
      POSTOPERATIVE IMMUNOSTIMULATION AFTER COMPLETE RESECTION IMPROVES SURVIVAL OF PATIENTS WITH STAGE-I NONSMALL CELL LUNG-CARCINOMA

      Cancer
    20. MORTON DL; BARTH A
      VACCINE THERAPY FOR MALIGNANT-MELANOMA

      Ca
    21. DOVEIL GC; FIERRO MT; NOVELLI M; APPINO A; BERTERO M; QUAGLINO P; BERNENGO MG
      ADJUVANT THERAPY OF STAGE IIIB MELANOMA WITH INTERFERON ALFA-2B - CLINICAL AND IMMUNOLOGICAL RELEVANCE

      Dermatology
    22. WALLACK MK; SIVANANDHAM M; BALCH CM; URIST MM; BLAND KI; MURRAY D; ROBINSON WA; FLAHERTY LE; RICHARDS JM; BARTOLUCCI AA; ROSEN L
      A PHASE-III RANDOMIZED, DOUBLE-BLIND, MULTIINSTITUTIONAL TRIAL OF VACCINIA MELANOMA ONCOLYSATE-ACTIVE SPECIFIC IMMUNOTHERAPY FOR PATIENTS WITH STAGE-II MELANOMA

      Cancer
    23. LEE YC; LUH SP; WU RM; LEE CJ
      ADJUVANT IMMUNOTHERAPY WITH INTRAPLEURAL STREPTOCOCCUS-PYOGENES (OK-432) IN LUNG-CANCER PATIENTS AFTER RESECTION

      Cancer immunology and immunotherapy
    24. ISENBERG J; KO H; PULVERER G; GRUNDMANN R; STUTZER H; PICHLMAIER H
      PREOPERATIVE IMMUNOSTIMULATION BY PROPIONIBACTERIUM-GRANULOSUM-KP-45 IN COLORECTAL-CANCER

      Anticancer research
    25. DUFOUR P; LANG JM; GIRON C; DUCLOS B; HAEHNEL P; JAECK D; JUNG JM; OBERLING F
      SODIUM DITIOCARB AS ADJUVANT IMMUNOTHERAPY FOR HIGH-RISK BREAST-CANCER - A RANDOMIZED STUDY

      Biotherapy
    26. OTTO T; GOEPEL M; RUBBEN H
      ADJUVANT LOCAL TREATMENT FOLLOWING CURATIVE TRANSURETHRAL RESECTION OF BLADDER-CARCINOMA

      Onkologie
    27. HAYAKAWA K; MITSUHASHI N; SAITO Y; TAKAHASHI M; KATANO S; SHIOJIMA K; FURUTA M; NIIBE H
      EFFECT OF KRESTIN (PSK) AS ADJUVANT TREATMENT ON THE PROGNOSIS AFTER RADICAL RADIOTHERAPY IN PATIENTS WITH NONSMALL CELL LUNG-CANCER

      Anticancer research
    28. TAN JKL; HO VC
      POOLED ANALYSIS OF THE EFFICACY OF BACILLE CALMETTE-GUERIN (BCG) IMMUNOTHERAPY IN MALIGNANT-MELANOMA

      The Journal of dermatologic surgery and oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 14:22:37